Extracorporeal photopheresis—New insights into an old procedure
Transfusion Medicine · 2026-02 · 36 (1) · 53-58
DOI: 10.1111/tme.13156 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Transfusion Medicine, online erschienen am 10.06.2025. Verfasst von Sabine Seiffert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Immunology, University Leipzig Medical Center, Leipzig, Germany. Hauptthemen laut MEDLINE: Photopheresis, Apoptosis, T-Lymphocytes, Cell Proliferation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saxocell Precision Therapy Cluster (German Federal Minstry of Education and Research, BMBF).
Abstract (Originalsprache)
Background
Extracorporeal photopheresis (ECP) is a safe immunomodulatory strategy that induces cell‐type selective apoptosis through photodynamic processes. Despite decades of use, the mechanisms underlying ECP remain largely unexplored, particularly in studies examining specific immune cell subsets in ex vivo setups.
Aims
This proof‐of‐concept pilot study presents data on apoptosis and proliferation of T‐lymphocytes following ex vivo ECP application to leukocyte concentrates (LC) and peripheral blood (PB) samples from healthy donors.
Methods
LC and PB were diluted to a haematocrit of 2% and treated with 8‐methoxypsoralen, followed by ECP (ECP+) or no ECP (ECP−) in a discontinued system. Apoptosis of mononuclear cells was assessed 48 h post‐ECP using annexin V and 7 Aminoactinomycin D (7‐AAD) staining with flow‐cytometric quantification. The proliferative capacity of non‐apoptotic T‐lymphocytes was measured after 72 h of post‐ECP stimulation with anti‐CD3/CD28 cross‐linking, using Violet Proliferation Dye 450.
Results
ECP exposure significantly reduced the median T‐cell receptor‐induced proliferation of viable T‐lymphocytes from both LC (4.6%, p = 0.02) and PB (4.2%, p = 0.03). However, 7‐AAD staining 48 h post‐ECP showed no significant differences in the proportions of apoptotic cells in this experimental model.
Conclusion
Ex vivo ECP treatment inhibited T‐lymphocyte proliferation in both LC and PB from healthy individuals, suggesting this as a key mode of action. Our findings highlight ECP's potential applications, including its implications for modern immune therapies' adverse effects. Further analyses of functional characteristics of remaining vital cells are necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Immunology, University Leipzig Medical Center, Leipzig, Germany.
- Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
- Comprehensive Cancer Center Central Germany (CCCG), Leipzig, Germany.
- Fraunhofer Institute for Cellular Therapies, Leipzig, Germany.
ORCID-Profile: Vladan Vučinić
Förderung
- Saxocell Precision Therapy Cluster (German Federal Minstry of Education and Research, BMBF)
Zitieren
APA
Seiffert, S., Kirchberg, J., Bach, E., Menger, V., Brückner, M., Sack, U., Köhl, U., Platzbecker, U., Boldt, A., Herling, M., & Vučinić, V. (2026). Extracorporeal photopheresis—New insights into an old procedure. Transfusion Medicine, 36(1), 53-58. https://doi.org/10.1111/tme.13156
Vancouver
Seiffert S, Kirchberg J, Bach E, Menger V, Brückner M, Sack U, et al. Extracorporeal photopheresis—New insights into an old procedure. Transfusion Medicine. 2026;36(1):53-58. doi:10.1111/tme.13156
BibTeX
@article{Seiffert2026,
author = {Seiffert, Sabine and Kirchberg, Janine and Bach, Enrica and Menger, Victoria and Brückner, Mandy and Sack, Ulrich and Köhl, Ulrike and Platzbecker, Uwe and Boldt, Andreas and Herling, Marco and Vučinić, Vladan},
title = {Extracorporeal photopheresis—New insights into an old procedure},
journal = {Transfusion Medicine},
year = {2026},
volume = {36},
number = {1},
pages = {53--58},
doi = {10.1111/tme.13156}
}
EUVIMED